Skip to main content
Log in

Biphasic effect of tricyclic antidepressants on the release of norepinephrine from the adrenergic nerves of the rabbit heart

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

The release of norepinephrine (NE) from the right atrium of the rabbit heart was used as a model to investigate biphasic effects due to tricyclic antidepressants, similar to those clinically observed in the treatment of depression and known as “therapeutic window”. Strips of the atrium were loaded with3H-NE, and then superfused by Krebs solution. The basal release and the electrical stimulation evoked release of3H-NE were measured in the presence and absence of four clinically used tricyclic antidepressants: imipramine, amitriptyline, desipramine and nortriptyline. In addition, guanethidine, an adrenergic neuron blocker, was also studied. At lower concentrations (0.5–10 µM) tricyclic antidepressants increased, whereas higher concentrations (50–100 µM), inhibited the evoked release of NE. This inhibition was not prevented by the alpha2 adrenoceptor antagonist yohimbine, excluding the possibility of alpha2 adrenoceptormediated inhibition of NE release. In higher concentrations the tricyclic antidepressants increased the basal release of NE in a Ca-independent way. Secondary amine derivatives were more potent inhibitors of the evoked release, and enhance the resting basal release of NE to a greater extent than the tertiary ones. Similarly, guanethidine (1–50 µM) also decreased the evoked release and increased the basal release of NE in a concentration dependent manner. Yohimbine failed to counteract the inhibition caused by guanethidine and the increment of the basal release was Ca-independent. It is concluded that the effect of tricyclic antidepressants in potentiating the release of NE is masked by their adrenergic neuron blocking properties, i.e. they inhibit the release of NE. Our findings are consistent with paradoxical clinical observations that some tricyclic antidepressants have therapeutic value only in lower plasma concentrations and they become ineffective at higher concentrations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Asberg M, Cronholm B, Sjöqvist F, Tuck D (1971) Relationship between plasma level and therapeutic effect of nortriptyline. Br Med J 3:331–334

    Google Scholar 

  • Baldessarini RJ (1985) Drugs and the treatment of psychiatric disorders. In: Gilman AG, Goodman LS, Rall TW, Murad F (eds) Goodman and Gilman's The pharmacological basis of therapeutics, 7th edn. MacMillan, New York, pp 387–445

    Google Scholar 

  • Bennet JF (1967) Is there a superior antidepressant? In: Garattini S and Dukes MNG (eds) Antidepressant drugs. Excerpta Medica International Congress Series No 122, Amsterdam, pp 375–393

  • Bickel MH, Weder HJ (1968) The total fate of a drug: kinetics and distribution, excretion and formation of 14 metabolites in rats treated with imipramine. Arch Int Pharmacodyn 173:433–463

    Google Scholar 

  • Biegon A, Samuel D (1979) The in vivo distribution of an antidepressant drug in male and female rats. Psychopharmacology 65:259–263

    Google Scholar 

  • Boyer WF, Lake CR (1987) Initial severity and diagnosis influence the relationship of tricyclic plasma levels to response: a statistical review. J Clin Psychopharmacol 7:67–71

    Google Scholar 

  • Brodie BB, Chang CC, Costa E (1965) On the mechanism of action of guanethidine and bretylium. Br J Pharmacol Chemother 25:171–178

    Google Scholar 

  • Christiansen J, Gram LF (1973) Imipramine and its metabolites in human brain. J Pharm Pharmacol 25:604–608

    Google Scholar 

  • Coryell W, Turner RD, Sherman A (1987) Desipramine plasma levels and clinical response: evidence for a curvilinear relationship. J Clin Psychopharmacol 7:138–142

    Google Scholar 

  • Costa E, Boullin DJ, Hammer W, Vogel W, Brodie BB (1966) Interactions of drugs with adrenergic neurons. Pharmacol Rev 18:577–597

    Google Scholar 

  • Eisenhofer G, Ropchak TG, Stull RW, Goldstein DS, Keiser HR, Kopin IJ (1987) Dihydroxyphenylglycol and intraneuronal metabolism of endogenous and exogenous norepinephrine in the rat vas deferens. J Pharmacol Exp Ther 241:547–553

    Google Scholar 

  • Glassman HA, Perel JM, Shostak M, Kantor SJ, Fleiss LJ (1977) Clinical implications of imipramine plasma levels for depressive illness. Arch Gen Psychiatry 34:197–204

    Google Scholar 

  • Heikkila RE, Goldfinger SS, Orlansky H (1976) The effect of various phenothiazines and tricyclic antidepressants on the accumulation and release of (3H)-norepinephrine and (3H)5-hydroxytryptamine in slices of rat occipital cortex. Res Commun Chem Pathol Pharmacol 13:237–250

    Google Scholar 

  • Hertting G, Axelrod J, Whitby LG (1961) Effect of drugs on the uptake and metabolism of3H-norepinephrine. J Pharmacol Exp Ther 134:146–153

    Google Scholar 

  • Hughes IE (1978) The effect of amitriptyline on presynaptic mechanisms in noradrenergic nerves. Br J Pharmacol 63:315–321

    Google Scholar 

  • Iversen LL (1965) Inhibition of noradrenaline uptake by drugs. J Pharm Pharmacol 17:62–64

    Google Scholar 

  • Kragh-Sorensen P, Hansen E, Baastrup PC, Hvidberg EF (1976) Self-inhibiting action of nortriptyline antidepressive effect at high plasma levels. Psychopharmacologia 45:305–312

    Google Scholar 

  • Lader M (1974) Plasma concentrations of tricyclic antidepressive drugs. Br J Clin Pharmacol 1:281–283

    Google Scholar 

  • Lindmar R, Löffelholz K, Muscholl E (1969) Unterschiede zwischen Tyramin und Dimethylphenylpiperazin in der Ca++ Abhangigkeit und im zeitlichen Verlauf der Noradrenalin-Freisetzung am isolierten Kaninchenherzen. Experientia 23:933–934

    Google Scholar 

  • Mandell AJ, Spooner CE, Winters WD, Cruikshank M, Sabbot IM (1968) Neurochemical correlates of the imipramine antagonism of the behavioral effects of norepinephrine. Life Sci 7:1317–1324

    Google Scholar 

  • Mitchell JR, Oates JA (1970) Guanethidine and related agents. I. Mechanism of selective blockade of adrenergic neurons and its antagonism by drugs. J Pharmacol Ther 172:100–107

    Google Scholar 

  • Nathan RS, Perel JM, Pollock BG, Kupfer DJ (1990) The role of neuropharmacologic selectivity in antidepressant action: fluvoxamine versus desipramine. J Clin Psychiatry 51:367–372

    Google Scholar 

  • Paton DM (1973) Mechanism of efflux of noradrenaline from adrenergic nerves in rabbit atria. Br J Pharmacol 49:614–627

    Google Scholar 

  • Perel JM, Wong SHY (1989) Therapeutic/toxicity tricyclic antidepressant (TCA) plasma level monitoring. Criteria and methodologies. In: Galteau MM, Siest G, Henny J (eds) Biologie Prospective, Compte rendus du 7e Colloque de Pont a Mousson, John Libbey Eurotext, Paris, pp 783–792

    Google Scholar 

  • Richelson E, Nelson B (1984) Antagonism by antidepressants of neurotransmitter receptors of human brain in vitro. J Pharmacol Exp Ther 230:94–102

    Google Scholar 

  • Sigg EB, Osborn M, Korol B (1963) Cardiovascular effects of imipramine. J Pharmacol Exp Ther 141:237–243

    Google Scholar 

  • Somogyi GT, Perel JM (1988) Inhibitory action of some tricyclic antidepressants (TCA) on the presynaptic muscarinic receptors of the adrenergic nerve terminals. Pharmacologist 30:A118

    Google Scholar 

  • Somogyi GT, Perel JM (1989a) Antagonism by tricyclic antidepressants of the muscarinic receptors located on the adrenergic nerve endings in rabbit heart atrium. J Pharmacol Exp Ther 251:922–928

    Google Scholar 

  • Somogyi GT, Perel JM (1989b) Biphasic effect of tricyclic antidepressants on the release of norepinephrine (NE) from the adrenergic nerves of rabbit heart. Pharmacologist A120

  • Sulser F (1984) Mode of action of antidepressant drugs. J Clin Psychiatry 44:14–20

    Google Scholar 

  • Titus EO, Matusek N, Spiegel HE, Brodie BB (1966) The effect of desmethylimipramine on uptake ofdl-norepinephrine-7-H3 in the heart. J Pharmacol Exp Ther 152:469–477

    Google Scholar 

  • Vizi ES (1979) Presynaptic modulation of neurochemical transmission. Prog Neurobiol 12:181–290

    Google Scholar 

  • Vizi ES, Somogyi GT, Harsing LG, Zimanyi I (1985) External Ca-independent release of norepinephrine by sympathomimetics and its role in negative feedback modulation. Proc Natl Acad Sci USA 82:8775–8779

    Google Scholar 

  • Vizi ES, Somogyi GT, Harsing LG Jr, Zimanyi I (1986) Release of [3H]noradrenaline by alpha1-adrenoceptor antagonists. Neurochem Res 11:71–84

    Google Scholar 

  • Weiner N (1985) Drugs that inhibit adrenergic nerves and block adrenergic receptors In: Gilman AG, Goodman LS, Rall TW, Murad F (ed) Goodman and Gilman's the pharmacological basis of therapeutics, 7th edn. MacMillan, New York, pp 181–214

    Google Scholar 

  • Westfall PD (1973) Antagonism by protriptyline and desipramine of the response of the vas deferens of the rat to norepinephrine, acetylcholine and potassium. J Pharmacol Exp Ther 185:540–550

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Somogyi, G.T., Perel, J.M. Biphasic effect of tricyclic antidepressants on the release of norepinephrine from the adrenergic nerves of the rabbit heart. Psychopharmacology 104, 237–243 (1991). https://doi.org/10.1007/BF02244185

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02244185

Key words

Navigation